论文部分内容阅读
目的探究氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床效果。方法 96例高血压合并冠心病患者,随机分为观察组和对照组,各48例。对照组服用氨氯地平片进行治疗,观察组服用氨氯地平阿托伐他汀钙片进行治疗;治疗结束后,对两组患者的血压变化情况进行监测,并且观察有无不良反应发生。结果观察组不良反应发生率为2.1%(1/48);对照组为4.2%(2/48),两组比较差异无统计学意义(P>0.05)。观察组患者治疗前后的血压变化情况明显好于对照组(P<0.05)。结论氨氯地平阿托伐他汀钙片用于治疗高血压合并冠心病具有起效快,药效平稳,且基本无不良反应发生的特征,治疗效果显著,值得在临床中推广使用。
Objective To investigate the clinical efficacy of amlodipine atorvastatin calcium in the treatment of patients with hypertension and coronary heart disease. Methods 96 cases of hypertension with coronary heart disease were randomly divided into observation group and control group, each 48 cases. The control group took amlodipine tablets for treatment, and the observation group took amlodipine atorvastatin calcium tablets for treatment. After the treatment, the changes of blood pressure in both groups were monitored and the adverse reactions were observed. Results The incidence of adverse reactions was 2.1% (1/48) in the observation group and 4.2% (2/48) in the control group. There was no significant difference between the two groups (P> 0.05). The observation group patients before and after treatment of blood pressure was significantly better than the control group (P <0.05). Conclusion Amlodipine atorvastatin calcium tablets for the treatment of hypertension with coronary heart disease has rapid onset, stable efficacy, and basically no adverse reactions occurred in the treatment of significant effect, it is worth to promote the use of the clinic.